Hertraz 440 mg Powder For Concentrate For Solution For Infusion

Nazione: Filippine

Lingua: inglese

Fonte: FDA (Food And Drug Administration)

Principio attivo:

Trastuzumab

Commercializzato da:

Mylan Laboratories Limited; Importer: Zuellig Pharma Corporation; Distributor: Zuellig Pharma Corporation

INN (Nome Internazionale):

Trastuzumab

Dosaggio:

440 mg

Forma farmaceutica:

Powder For Concentrate For Solution For Infusion

Confezione:

Each box contains: One 50 mL USP Type I glass vial with chlorobutyl rubber stopper and aluminum seal with blue flip-off cap (drug product) + Two 15 mL (Net content: 10 mL) USP Type I glass vial (1.1% bacteriostatic water for injection as diluent), Each box contains: One 50 mL USP Type I glass vial with chlorobutyl rubber stopper and aluminum seal with blue flip-off cap (d

Prodotto da:

Biocon Limited, India

Data dell'autorizzazione:

2022-08-18